{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:13:48Z","timestamp":1794694428823,"version":"4.9.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cpcardiol.2021.101082","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T18:34:46Z","timestamp":1639247686000},"page":"101082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"title":["Peripheral Artery Disease: A Comprehensive Updated Review"],"prefix":"10.1016","volume":"47","author":[{"given":"Garba Rimamskep","family":"Shamaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Favour","family":"Markson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demilade","family":"Soji-Ayoade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibuike Charles","family":"Agwuegbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Olaseni","family":"Bamgbose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5227-9478","authenticated-orcid":false,"given":"Bob-Manuel","family":"Tamunoinemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2021.101082_bib0001","doi-asserted-by":"crossref","first-page":"e980","DOI":"10.1016\/S2214-109X(19)30293-1","article-title":"Differential burden of peripheral artery disease","volume":"7","author":"Kengne","year":"2019","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0002","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2006.03.011","article-title":"Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review","volume":"189","author":"Heald","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0003","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.semvascsurg.2021.02.005","article-title":"Epidemiology of peripheral artery disease","volume":"34","author":"Eid","year":"2021","journal-title":"Seminars in Vascular Surgery"},{"issue":"2","key":"10.1016\/j.cpcardiol.2021.101082_bib0004","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jvs.2017.06.102","article-title":"Estimated annual health care expenditures in individuals with peripheral arterial disease","volume":"67","author":"Scully","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0005","unstructured":"Peripheral artery disease \u2014 Level 3 cause | Institute for Health Metrics and Evaluation. Accessed September 24, 2021. http:\/\/www.healthdata.org\/results\/gbd_summaries\/2019\/peripheral-artery-disease-level-3-cause."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0006","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.atherosclerosis.2019.05.026","article-title":"Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample","volume":"286","author":"Kohn","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ehjqcco\/qcx028","article-title":"Long-term cardiovascular outcome, use of resources, and healthcare costs in patients with peripheral artery disease: results from a nationwide Swedish study","volume":"4","author":"Hasvold","year":"2018","journal-title":"Eur Heart Journal - Quality of Care and Clinical Outcomes"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0008","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4065\/mcp.2010.0133","article-title":"Peripheral artery disease: current insight into the disease and its diagnosis and management","volume":"85","author":"Olin","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0009","first-page":"362","article-title":"Lower extremity peripheral artery disease: diagnosis and treatment","volume":"99","author":"Firnhaber","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1358863X11431106","article-title":"Progression of asymptomatic peripheral artery disease over 1 year","volume":"17","author":"Mohler","year":"2012","journal-title":"Vasc Med"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0011","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2018.08.002","article-title":"Pathology of peripheral artery disease in patients with critical limb ischemia","volume":"72","author":"Narula","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0012","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/ATVBAHA.120.312862","article-title":"Vascular regeneration in peripheral artery disease","volume":"40","author":"Cooke","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2021.101082_bib0013","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/01.ATV.0000168911.78624.b7","article-title":"Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review","volume":"25","author":"Doobay","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0014","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4093\/dmj.2018.42.1.63","article-title":"Color doppler ultrasonography is a useful tool for diagnosis of peripheral artery disease in type 2 diabetes mellitus patients with ankle-brachial index 0.91 to 1.40","volume":"42","author":"Hur","year":"2018","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1067\/mva.2001.111734","article-title":"Interobserver variability in aortoiliac and femoropopliteal duplex scanning","volume":"33","author":"Ubbink","year":"2001","journal-title":"J Vasc Surg."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0016","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/CIRCIMAGING.111.970814","article-title":"Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions","volume":"5","author":"Pollak","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0017","first-page":"379","article-title":"La pression transcutan\u00e9e D'oxyg\u00e8ne (TcPO2): int\u00e8r\u00eats et limites [Transcutaneous oxygen pressure (TcPO2): advantages and limitations]","volume":"24","author":"Got","year":"1998","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0018","first-page":"565","article-title":"Transcutaneous oxygen pressure as a surrogate index of lower limb amputation","volume":"35","author":"Nishio","year":"2016","journal-title":"Int Angiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0019","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/jcm10071413","article-title":"What is currently the role of TcPO2 in the choice of the amputation level of lower limbs? A comprehensive review","volume":"10","author":"Catella","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0020","series-title":"Expert Radiology, Image-Guided Interventions","article-title":"3 - Clinical Vascular Examination, editor(s)","author":"Sophie","year":"2020"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.RVI.0000191361.02857.DE","article-title":"MD CT angiography of peripheral arterial disease","volume":"17","author":"Flaischmann","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0022","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00270-018-1979-z","article-title":"CT angiography in the lower extremity peripheral artery disease feasibility of an ultra-low volume contrast media protocol","volume":"41","author":"Horehledova","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0023","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jama.301.4.415","article-title":"Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis","volume":"301","author":"Met","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0024","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1538574417698906","article-title":"CT angiography of peripheral arterial disease by 256-slice scanner: accuracy, advantages and disadvantages compared to digital subtraction angiography","volume":"51","author":"Mishra","year":"2017","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0025","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1007\/s00330-013-2933-8","article-title":"Diagnostic performance of computed tomography angiography and contrast-enhanced magnetic resonance angiography in patients with critical limb ischaemia and intermittent claudication: systematic review and meta-analysis","volume":"23","author":"Jens","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0026","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.semnephrol.2011.05.010","article-title":"Gadolinium-induced nephrogenic systemic fibrosis","volume":"31","author":"Hellman","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0027","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1371\/journal.pone.0000246","article-title":"Patient acceptance of noninvasive and invasive coronary angiography","volume":"2","author":"Sch\u00f6nenberger","year":"2007","journal-title":"PLoS ONE"},{"issue":"4-6","key":"10.1016\/j.cpcardiol.2021.101082_bib0028","first-page":"271","article-title":"Digital substraction angiography in interventional radiology American journal of Roentgenology","volume":"6","author":"Kaufmann","year":"1983","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0029","first-page":"174","article-title":"Digital Subtraction Angiography or Computed Tomography Angiography in the Preoperative Evaluation of Lower Limb Peripheral Artery Disease - A Comparative Analysis","volume":"24","author":"Dias-Neto","year":"2017","journal-title":"Rev Port Cir Cardiotorac Vasc."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0030","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jvs.2014.08.064","article-title":"Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease","volume":"60","author":"Armstrong","year":"2014","journal-title":"J Vascular Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0031","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.05.049","article-title":"Cigarette smoking, smoking cessation, and long-term risk of 3 major atherosclerotic diseases","volume":"74","author":"Ding","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0032","first-page":"e726","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0033","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/bjs.9207","article-title":"Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial","volume":"100","author":"Fakhry","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3810\/psm.2012.05.1964","article-title":"Exercise interventions for patients with peripheral arterial disease: a review of the literature","volume":"40","author":"Brenner","year":"2012","journal-title":"Phys Sportsmed"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jacbts.2020.08.012","article-title":"Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease","volume":"6","author":"Biswas","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0036","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2217\/clp.12.6","article-title":"LDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality?","volume":"7","author":"Pollak","year":"2012","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0037","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.295.5.547","article-title":"Medical treatment of peripheral arterial disease","volume":"295","author":"Hankey","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003748.pub4","article-title":"Cilostazol for intermittent claudication","author":"Bedenis","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0039","first-page":"322","article-title":"Effects of the anti-platelet agent Cilostazol on peripheral vascular disease in patients with diabetes mellitus","volume":"42","author":"Uchikawa","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0040","first-page":"1531","article-title":"Effects of Cilostazol on platelet function","volume":"39","author":"Uehara","year":"1989","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0041","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0042","doi-asserted-by":"crossref","first-page":"b603","DOI":"10.1136\/bmj.b603","article-title":"Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data","volume":"338","author":"De Backer","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0043","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Association of statin dose with amputation and survival in patients with peripheral artery disease","volume":"137","author":"Arya","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0044","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1358836X9800300314","article-title":"Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events","volume":"3","author":"Creager","year":"1998","journal-title":"Vasc Med"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjmed.2004.01.014","article-title":"Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis","volume":"116","author":"Schleinitz","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0046","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials","volume":"301","author":"Berger","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0047","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.cpcardiol.2021.101082_bib0048","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"COMPASS Investigators. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0049","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/SLA.0000000000001676","article-title":"Endovascular versus open revascularization for peripheral arterial disease","volume":"265","author":"Wiseman","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.avsg.2019.06.039","article-title":"Comparison between endovascular and open surgery for the treatment of peripheral artery diseases: a meta-analysis","volume":"62","author":"Tang","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0051","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11892-005-0063-7","article-title":"Peripheral arterial disease: clinical assessment and indications for revascularization in the patient with diabetes","volume":"5","author":"Muhs","year":"2005","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0052","first-page":"37","article-title":"Critical limb ischemia","volume":"33","author":"Elsayed","year":"2015","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0053","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.CIR.89.1.511","volume":"89","author":"Pentecost","year":"1994","journal-title":"Circulation."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0054","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0021-9150(87)90037-2","article-title":"Influence of pressure on permeability of normal and diseased muscular arteries to horseradish peroxidase. A new catheter approach","volume":"65","author":"Goldman","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0055","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1055\/s-0038-1676360","article-title":"Drug-eluting balloons and drug-eluting stents in the treatment of peripheral vascular disease","volume":"35","author":"Lindquist","year":"2018","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0056","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0057","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0058","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Scheinert D; LEVANT 2 Investigators. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0059","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0060","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.jacc.2012.07.033","article-title":"Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis","volume":"60","author":"Stabile","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0061","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1526602815614555","article-title":"Paclitaxel-eluting balloon vs standard angioplasty to reduce restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: three-year results of the DEBATE-ISR study","volume":"23","author":"Grotti","year":"2016","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0062","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijsu.2017.04.057","article-title":"Paclitaxel-coated versus uncoated balloon angioplasty for femoropopliteal artery in-stent restenosis","volume":"42","author":"Wu","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0063","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.jcin.2017.06.018","article-title":"IN.PACT global study investigators. drug-coated balloon treatment for femoropopliteal artery disease: the IN.PACT global study De Novo In-Stent restenosis imaging cohort","volume":"10","author":"Brodmann","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0064","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0065","first-page":"1090","article-title":"Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions","volume":"74","author":"Dick","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0066","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0067","doi-asserted-by":"crossref","first-page":"790","DOI":"10.4244\/EIJV12I6A128","article-title":"Fluorocopolymer-coated nitinol self-expanding paclitaxel-eluting stent: pharmacokinetics and vascular biology responses in a porcine iliofemoral model","volume":"12","author":"Hou","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0068","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/1526602816650206","article-title":"Twelve-month results from the MAJESTIC trial of the eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease","volume":"23","author":"M\u00fcller-H\u00fclsbeck","year":"2016","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0069","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004450","article-title":"Impact of fluoropolymer-based paclitaxel delivery on neointimal proliferation and vascular healing: a comparative peripheral drug-eluting stent study in the familial hypercholesterolemic swine model of femoral restenosis","volume":"10","author":"Gasior","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0070","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","article-title":"Two-Year efficacy and safety results from the IMPERIAL randomized study of the eluvia polymer-coated drug-eluting stent and the Zilver PTX polymer-free drug-coated stent","volume":"44","author":"M\u00fcller-H\u00fclsbeck","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0071","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0072","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007559","article-title":"Femoropopliteal In-Stent Restenosis","volume":"11","author":"Rymer","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0073","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jacc.2005.09.045","article-title":"Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer?","volume":"47","author":"Azarbal","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2 Suppl 2","key":"10.1016\/j.cpcardiol.2021.101082_bib0074","first-page":"II105","article-title":"Atherectomy for infrainguinal peripheral artery disease","volume":"16","author":"Garcia","year":"2009","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0075","article-title":"Atherectomy for peripheral arterial disease","volume":"17","author":"Ambler","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0076","first-page":"135","article-title":"Atherectomy in peripheral artery disease: a review","volume":"29","author":"Bhat","year":"2017","journal-title":"J Invasive Cardiol"},{"issue":"3 Suppl","key":"10.1016\/j.cpcardiol.2021.101082_bib0077","first-page":"IV79","article-title":"Directional atherectomy. New approaches for treatment of obstructive coronary and peripheral vascular disease","volume":"81","author":"Hinohara","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0078","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jcin.2014.05.006","article-title":"Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study","volume":"7","author":"McKinsey","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0079","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/1526602817701720","volume":"24","author":"Schwindt","year":"2017","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0080","series-title":"Treasure Island (FL)","article-title":"StatPearls [Internet]","author":"Shipman","year":"2021"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0081","first-page":"115","article-title":"Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: the CONFIRM series, a prospective multicenter registry","volume":"83","author":"Das","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0082","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1538574406291796","article-title":"Laser atherectomy for lower extremity revascularization: an adjunctive endovascular treatment option","volume":"40","author":"Zhou","year":"2006","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0083","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.carrev.2020.10.016","article-title":"Excimer laser atherectomy in percutaneous coronary intervention: a contemporary review","volume":"25","author":"Tsutsui","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0084","doi-asserted-by":"crossref","first-page":"27","DOI":"10.15420\/icr.2016:2:2","article-title":"Coronary Intervention with the Excimer Laser: review of the technology and outcome data","volume":"11","author":"Rawlins","year":"2016","journal-title":"Interv Cardiol"},{"issue":"1 Pt A","key":"10.1016\/j.cpcardiol.2021.101082_bib0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcin.2014.09.009","volume":"8","author":"Dippel","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0086","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jcin.2013.12.196","article-title":"Current status of rotational atherectomy","volume":"7","author":"Tomey","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0087","doi-asserted-by":"crossref","first-page":"182","DOI":"10.15420\/icr.2019.17.R1","article-title":"Rotational atherectomy: a contemporary appraisal","volume":"14","author":"Gupta","year":"2019","journal-title":"Interv Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0088","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1583\/09-2826.1","article-title":"One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial","volume":"16","author":"Zeller","year":"2009","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0089","first-page":"227","article-title":"Early experience in the application of distal protection devices in treatment of peripheral vascular disease of the lower extremities","volume":"64","author":"Wholey","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0090","unstructured":"Millie Liao, DO, MS1; Kenneth Huynh2; Christopher Molloy, MD3; Kyle J. Cooper, MD. Review of Embolic protection devices in percutaneous peripheral interventions. Vascular disease management 2021;18:E95-8."},{"issue":"5 Suppl","key":"10.1016\/j.cpcardiol.2021.101082_bib0091","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jvs.2010.01.073","volume":"51","author":"Bradbury","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0092","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"Society for vascular surgery lower extremity guidelines committee. the society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J Vasc Surg."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0093","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1148\/radiographics.21.5.g01se281239","article-title":"Distal venous arterialization for lower limb salvage: angiographic appearances and interventional procedures","volume":"21","author":"Engelke","year":"2001","journal-title":"Radiographics"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0094","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jvs.2019.10.085","article-title":"Open, percutaneous, and hybrid deep venous arterialization technique for no-option foot salvage","volume":"71","author":"Ho","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0095","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.avsg.2010.07.012","article-title":"Management of lower extremity wounds in patients with peripheral arterial disease: a stratified conservative approach","volume":"24","author":"Chiriano","year":"2010","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0096","unstructured":"Yost M. PAD costs economics amputation costs economics, critical limb ischemia, chronic venous disease, venous ulcers, chronic venus insufficiency - CLI US Supplement 2016The Sage Group. Available at:http:\/\/thesagegroup.us\/pages\/reports\/cli-us-supplement-2016.php. Accessed August 18, 2018"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0097","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clindermatol.2006.12.005","article-title":"Impaired wound healing","volume":"25","author":"Menke","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0098","doi-asserted-by":"crossref","first-page":"H765","DOI":"10.1152\/ajpheart.00247.2019","article-title":"Exosomes derived from induced vascular progenitor cells promote angiogenesis in vitro and in an in vivo rat hindlimb ischemia model","volume":"317","author":"Johnson","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0099","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature13839","article-title":"Mesenchymal-endothelial transition contributes to cardiac neovascularization","volume":"514","author":"Ubil","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.cpcardiol.2021.101082_bib0100","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.jcin.2018.05.025","article-title":"Embolic protection system in lower extremity arterial interventions: results of the pivotal WISE LE trial","volume":"11","author":"Shammas","year":"2018","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621002905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621002905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:06:16Z","timestamp":1758938776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280621002905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0146280621002905"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.101082","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral Artery Disease: A Comprehensive Updated Review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.101082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101082"}}